Implantation outside the uterine cavity — most commonly tubal; life-threatening hemorrhage if ruptured.
Also known as: ectopic pregnancy, tubal pregnancy, ruptured ectopic, heterotopic pregnancy
Overview
Implantation of a fertilized ovum outside the uterine cavity; ~95% occur in the fallopian tube (ampulla most common). Non-tubal sites include cornual/interstitial, cervical, ovarian, abdominal, and cesarean scar pregnancies.
Epidemiology
~1-2% of all pregnancies in the US. Leading cause of first-trimester maternal death; ruptured ectopic accounted for 2.7% of all US pregnancy-related deaths in 2011-2013 and was the leading cause of hemorrhage-related maternal death. Higher incidence with ART and PID.
Try two board-style Ectopic Pregnancy questions
Real questions from the FirstPassPA bank, with the full explanation. Pick an answer — no signup, no email.
Question 1ReproductiveMedium
A 16-year-old girl presents with severe lower abdominal pain and vaginal bleeding. Last menstrual period was 7 weeks ago. β-human chorionic gonadotropin (β-hCG) is 4,200 mIU/mL. Transvaginal ultrasound shows no intrauterine pregnancy and free pelvic fluid. BP is 82/54 mmHg and HR is 128/min. Which of the following is the most appropriate immediate management?
AEmergent surgical exploration
BDiagnostic laparoscopy after stabilization
CSingle-dose intramuscular methotrexate
DEmergent dilation and curettage
EBlood transfusion with inpatient observation
Reveal answer & full explanation
Correct answer: A — Emergent surgical exploration
AEmergent surgical exploration✓
BDiagnostic laparoscopy after stabilization
CSingle-dose intramuscular methotrexate
DEmergent dilation and curettage
EBlood transfusion with inpatient observation
Why Emergent surgical exploration is correct
This is a ruptured ectopic pregnancy with hemodynamic instability (BP 82/54 mmHg, HR 128/min), which is a surgical emergency.
Free pelvic fluid on ultrasound indicates hemoperitoneum from rupture.
No intrauterine pregnancy on transvaginal ultrasound (TVUS) with β-human chorionic gonadotropin (β-hCG) of 4,200 mIU/mL — above even a conservatively high discriminatory level (about 3,500 mIU/mL) — raises high suspicion for ectopic pregnancy.
Management: immediate IV access, type and crossmatch, fluid resuscitation, and emergent operating room for salpingectomy.
Why the others are wrong
Blood transfusion with inpatient observation — Transfusion supports the circulation but provides no source control; hemorrhage from the ruptured tube continues until it is operatively removed, so resuscitation must accompany surgery rather than substitute for it.
Diagnostic laparoscopy after stabilization — Diagnostic laparoscopy is the appropriate surgical approach when stable; however, with frank hemodynamic instability and suspected rupture, emergent exploration (which may require laparotomy) takes priority over a staged approach.
Single-dose intramuscular methotrexate — Contraindicated in this setting; methotrexate requires hemodynamic stability and no active bleeding.
Emergent dilation and curettage — uterine evacuation is the emergency procedure for hemorrhage from an incomplete miscarriage, and vaginal bleeding at 7 weeks invites that frame, but no intrauterine pregnancy on TVUS despite a β-hCG above the discriminatory level, together with free pelvic fluid and shock, places the source of hemorrhage outside the uterus in a ruptured ectopic pregnancy; curettage cannot control it and only delays the operation that can.
Question 2ReproductiveMedium
A 26-year-old woman presents with sudden unilateral pelvic pain, vaginal spotting, and 7 weeks of amenorrhea. Beta-hCG is 2,800 mIU/mL. Transvaginal ultrasound shows no intrauterine pregnancy and a 2.5-cm right adnexal gestational sac with a yolk sac, separate from the ovary, with no embryonic cardiac activity and no free fluid. She is hemodynamically stable, and her CBC, creatinine, and liver enzymes are normal. What is the management?
AMethotrexate 50 mg/m2 IM
BDilation and curettage
CVaginal misoprostol
DMifepristone 200 mg orally
ERepeat beta-hCG in 48 hours
Reveal answer & full explanation
Correct answer: A — Methotrexate 50 mg/m2 IM
AMethotrexate 50 mg/m2 IM✓
BDilation and curettage
CVaginal misoprostol
DMifepristone 200 mg orally
ERepeat beta-hCG in 48 hours
Why Methotrexate 50 mg/m2 IM is correct
An extrauterine gestational sac with a yolk sac and no intrauterine pregnancy (IUP) on transvaginal ultrasound (TVUS) confirms a tubal ectopic pregnancy, whatever the hCG level
Methotrexate is appropriate when criteria are met: hemodynamic stability, no rupture, hCG below 5,000 mIU/mL, ectopic mass below 3.5 cm, no fetal cardiac activity, and normal renal/hepatic/CBC labs; this patient is stable with an hCG of 2,800 mIU/mL, a 2.5-cm unruptured mass without cardiac activity, and normal labs
Why the others are wrong
Repeat beta-hCG in 48 hours — serial hCG is for a pregnancy of unknown location; here the ectopic is already visualized, so waiting only delays treatment and risks rupture
Dilation and curettage — does not treat a tubal ectopic pregnancy
Vaginal misoprostol — a uterotonic that expels an intrauterine gestation; it has no effect on trophoblast implanted in the tube and leaves the ectopic in place to rupture
Mifepristone 200 mg orally — a progesterone-receptor antagonist that, paired with misoprostol, is used for medication abortion and early pregnancy loss; it acts on an intrauterine gestation, and its label lists confirmed or suspected ectopic pregnancy as a contraindication because it does not end a tubal pregnancy, leaving the ectopic in place to rupture
Additional high-yield points
Without a visualized ectopic, an empty uterus at hCG 2,800 mIU/mL is a pregnancy of unknown location: ACOG sets the discriminatory level conservatively high (up to about 3,500 mIU/mL) and does not recommend presumptive methotrexate, which is teratogenic if a viable IUP is present
Unlock the full FirstPassPA bank: 7,700+ board-style questions, flashcards, and an AI tutor that explains every answer. Your 7-day free trial includes everything, and there's no credit card required.
You've read your 2 free diagnosis previews. Create your free account to unlock the full Ectopic Pregnancy outline — plus all 514 diagnoses, 7,700+ board-style questions, flashcards, and an AI tutor. Your 7-day free trial includes everything, and there's no credit card required.
Prior tubal surgery (sterilization, reanastomosis)
Tubal pathology (PID, salpingitis, hydrosalpinx)
Pregnancy with IUD in place
Assisted reproductive technology
Endometriosis
Smoking
Diethylstilbestrol exposure (historical)
Infertility, advanced maternal age
Pathophysiology
Damaged or dysfunctional fallopian tubes impair ovum transport, leading to implantation in tubal mucosa. As trophoblast invades the thin tubal wall, hemorrhage occurs, leading to tubal distension, abortion, or rupture with intraperitoneal hemorrhage. β-hCG production is typically lower than in intrauterine pregnancy and rises more slowly.
Clinical presentation
Symptoms
Amenorrhea (missed period)
Unilateral pelvic or abdominal pain
Vaginal bleeding (often light)
Shoulder tip pain (referred from diaphragmatic blood)
Dizziness, syncope (hemorrhage)
Some are asymptomatic and detected on early pregnancy ultrasound
Heterotopic pregnancy — Concurrent intrauterine and ectopic — rare except with ART (~1:100 vs 1:30,000 spontaneous)
Diagnostic workup
Diagnostic criteria
Pregnancy of unknown location: positive β-hCG without IUP or extrauterine findings on TVUS — requires serial β-hCG and possibly D&C to distinguish failed IUP from ectopic. Ectopic confirmed by visualization of extrauterine pregnancy or by absence of chorionic villi on D&C with persistent or rising β-hCG.
Labs
Quantitative serum β-hCG — discriminatory zone ~1500-3500 mIU/mL above which intrauterine pregnancy should be visible on TVUS; ACOG advises a conservatively high threshold (~3,500) before calling an empty uterus abnormal, and methotrexate should not be given until a viable IUP has been reasonably excluded (teratogenic; presumptive treatment has no proven benefit)
Serial β-hCG every 48 hours: minimal 48-h rise for a potentially viable IUP depends on the starting level (ACOG: ~49% if <1,500, 40% if 1,500-3,000, 33% if >3,000 mIU/mL) and a normal rise does not exclude ectopic; abnormal rise/plateau/fall suggests nonviable IUP or ectopic
CBC (anemia from bleeding), type and screen, Rh status
Quantitative β-hCG after definitive treatment to confirm resolution (<5 mIU/mL)
Imaging
Transvaginal ultrasound — primary imaging; look for intrauterine gestational sac (with yolk sac or embryo), adnexal mass, free fluid in pelvis
Doppler may show 'ring of fire' (vascular ectopic)
Definitive: extrauterine gestational sac with yolk sac/embryo or extrauterine cardiac activity
Pseudogestational sac (collapsed fluid in endometrial cavity) can mimic IUP — careful evaluation
Diagnostic algorithm
flowchart TD
A[Positive β-hCG +<br/>pain/bleeding] --> B[Hemodynamic status]
B -->|Unstable / rupture| C[Emergent laparoscopic<br/>salpingectomy<br/>blood products]
B -->|Stable| D[TVUS + quantitative β-hCG]
D --> E{IUP visible?}
E -->|Yes| F[Intrauterine pregnancy<br/>± heterotopic if ART/risk]
E -->|Ectopic seen| G[Treat ectopic]
E -->|Indeterminate| H{β-hCG vs<br/>discriminatory zone}
H -->|Above + no IUP| I[Likely ectopic or<br/>nonviable IUP — repeat US,<br/>± D&C, treat as ectopic if confirmed]
H -->|Below| J[Repeat β-hCG in 48 h]
J --> K{"Rise ≥ expected minimum<br/>for starting hCG?"}
K -->|Yes| L[Likely IUP — repeat US<br/>when above zone]
K -->|No| M[Nonviable: ectopic or<br/>failed IUP — definitive workup]
G --> N{MTX candidate?}
N -->|Yes| O[Methotrexate IM<br/>+ serial β-hCG]
N -->|No| P[Laparoscopic surgery]
Algorithm for suspected ectopic pregnancy.
Treatment
First-line
Hemodynamically unstable, ruptured, or large ectopic: emergent surgery (laparoscopic salpingectomy preferred over salpingostomy)
Anti-D immunoglobulin (RhoGAM) for Rh-negative women
All require post-treatment β-hCG monitoring until <5 mIU/mL
Methotrexate (medical management)
Single-dose protocol: methotrexate 50 mg/m² IM; check β-hCG day 4 and day 7; expect ≥15% decline from day 4 to day 7; weekly until <5 mIU/mL
Two-dose and multi-dose protocols for larger or higher β-hCG ectopics
Criteria: hemodynamically stable, no rupture, β-hCG ideally <5000 mIU/mL, ectopic size <3.5-4 cm, no fetal cardiac activity, no significant free fluid, reliable follow-up
Contraindications: hemodynamic instability, hepatic/renal/hematologic disease, immunodeficiency, peptic ulcer, breastfeeding, intrauterine pregnancy, inability to follow up
Surgical management
Laparoscopic salpingectomy — preferred for ruptured, large, or recurrent ectopic; complete removal of affected tube
Laparoscopic salpingostomy — fertility-preserving, but ~10% require additional treatment for persistent trophoblast; check post-op β-hCG weekly
Laparotomy — typically reserved for unstable patients, large hemoperitoneum, or poor laparoscopic visualization (ACOG); in an unstable patient use the most expedient route (laparoscopy if expertise allows), usually with salpingectomy
Expectant management
Selected very-early ectopics with low and falling β-hCG, no symptoms, reliable follow-up
Serial β-hCG until <5 mIU/mL
Complications
Hemorrhage and hemorrhagic shock — most common cause of first-trimester maternal mortality
Tubal rupture
Loss of fallopian tube → reduced future fertility
Recurrent ectopic (10% risk)
Methotrexate side effects: bone marrow suppression, hepatotoxicity, mucositis, pneumonitis
Persistent trophoblast after salpingostomy
PANCE pearls
Always check β-hCG in any reproductive-age woman with abdominal pain or abnormal bleeding.
Heterotopic pregnancy is rare spontaneously (1:30,000) but more common with ART (~1:100) — ALWAYS evaluate adnexa even when IUP is identified.
Methotrexate is contraindicated with concurrent IUP, hepatic/renal disease, hematologic disorders, immunodeficiency, peptic ulcer, breastfeeding, or unreliable follow-up.
Beware of pseudogestational sac (collapsed fluid in endometrial cavity); look for true yolk sac or embryo to confirm IUP.
Rh-negative, unsensitized patient with an ectopic pregnancy: give anti-D immune globulin (RhoGAM 50 mcg if <12 weeks, 300 mcg if ≥12 weeks); SFP still recommends it for ectopic pregnancy. For spontaneous or induced abortion before 12 weeks, ACOG (2024) now suggests forgoing routine Rh testing and RhIG, individualized by shared decision-making.
After methotrexate, advise avoiding alcohol, NSAIDs, folic acid supplements, sexual intercourse, sun exposure, and pregnancy for at least 3 months.
ASRM 2013 — Medical Treatment of Ectopic Pregnancy: A Committee Opinion (Fertil Steril 2013)
Stovall Protocol — Single-dose Methotrexate: An Expanded Clinical Trial (Stovall and Ling, Am J Obstet Gynecol 1993)
ACOG CPU 2024 — ACOG Clinical Practice Update: Rh D Immune Globulin Administration After Abortion or Pregnancy Loss at Less Than 12 Weeks of Gestation. Obstet Gynecol 2024;144(6):e140-e143
Practice Reproductive questions on FirstPassPA
Turn this outline into retention. 7,700+ board-style questions with an AI tutor that explains every answer — free to start, no card required.
Educational use only. This outline is a study aid for PA students and is not medical advice or a substitute for clinical judgment. FirstPassPA is an independent study tool and is not affiliated with, endorsed by, or sponsored by NCCPA or PAEA. PANCE® and PANRE® are registered trademarks of the National Commission on Certification of Physician Assistants; End of Rotation™ is a program of the Physician Assistant Education Association.